This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05964413
Recruitment Status : Recruiting
First Posted : July 27, 2023
Last Update Posted : March 4, 2024
Information provided by (Responsible Party):
InflaRx GmbH

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 13, 2026
Estimated Study Completion Date : May 15, 2026